Search Results 101-110 of 17205 for hba1c

  1. Safety And Efficacy Of Selonsertib In Adults With Compensated Cirrhosis Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    HbA1c ≤ 9.5% (or serum fructosamine ≤ 381 μmol if HbA1c is unable to be resulted). Exclusion Criteria: Prior history of decompensated liver disease ...

  2. Blood Tests (Phlebotomy)​ - Mayo Clinic Healthcare

    Blood glucose and HbA1c: Measures blood sugar levels to check for or manage diabetes; Biochemistry tests: Assess kidney function, liver function, and ...

  3. A Study of PDD in Type 2 Diabetes - Clinical Trials

    HbA1C > 9 % at enrollment. Prior diagnosis, or signs and symptoms, of heart failure. Currently taking a loop diuretic. Myocardial infarction within 6 months ...

  4. Safety And Efficacy Of Selonsertib In Adults With Compensated Cirrhosis Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    HbA1c ≤ 9.5% (or serum fructosamine ≤ 381 μmol if HbA1c is unable to be resulted). Exclusion Criteria: Prior history of decompensated liver disease ...

  5. A Study To Evaluate The Effectiveness And Safety Of Relacorilant - Mayo Clinic

    Has severe, uncontrolled hypertension (mean SBP > 170 mm Hg or mean DBP > 110 mm Hg at Screening), based on 24-hour ABPM. · Has poorly controlled DM (HbA1c > 12% ...

  6. Taselisib And Enzalutamide In Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Fasting plasma glucose =< 160 mg/dL (7.49 mmol/L) and glycosylated hemoglobin (HbA1c) < 7.5 % or International Federation of Clinical Chemistry (IFCC) < 53 ...

  7. INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) - Mayo Clinic

    HbA1c ≥ 8%;; NOTE: HbA1c is not a required screening lab; however, if HbA1C is performed at screening, result must be < 8%. NOTE: If patient's HbA1c is ≥ 8 ...

  8. A Study Comparing The Effectiveness And Safety Of The Morning Injection Of Toujeo Versus Lantus In Patients With Type 1 Diabetes Mellitus - Mayo Clinic

    Glycated hemoglobin (HbA1c) <7.0% or >9.0% via central lab test at visit 1; Experienced none or only 1 episode of documented symptomatic and/or severe ...

  9. A Study to Evaluate Proinsulin and Glucagon Secretion in Postpartum Women with and without Gestational Diabetes - Mayo Clinic

    Women with an HbA1c of ≥ 5.7% (39mmol/mol) in early pregnancy or a history of diabetes. Prior therapy with an anti-diabetic medication, or a medication ...

  10. A Study of the Impact of Decision Aids to Enhance Shared Decision Making for Diabetes - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...